Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$279.78M
Total Bought
$9.92M
Total Sold
$10.76M
Net Transaction
-$846.9K
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
VAXCYTE INC(PCVX)1,372,4251,372,425063,32479,75228.51%+16,428
EVOMMUNE INC1,926,9431,926,943032,98944,30015.83%+11,311
AVALO THERAPEUTICS INC(AVTX)0295,933+295,93304,4181.58%+4,418
TREVI THERAPEUTICS INC(TRVI)1,256,7821,553,726+296,94415,73518,5366.63%+2,801
BIOAGE LABS INC(BIOA)653,374653,37408,64411,4284.08%+2,783
RALLYBIO CORP0300,579+300,57902,6960.96%+2,696
MAPLIGHT THERAPEUTICS INC(MPLT)611,447611,447010,74312,4314.44%+1,688
IMMUNOME INC(IMNM)732,512732,512015,73416,0205.73%+286
BOLT BIOTHERAPEUTICS INC94,57342,581-51,9925171720.06%-345
RECURSION PHARMACEUTICALS IN(RXRX)595,518595,51802,4361,8280.65%-607
OCULIS HOLDING AG2,288,6581,680,283-608,37545,70544,67915.97%-1,026
RALLYBIO CORP2,404,6440-2,404,6441,6500-1,650
ARCUTIS BIOTHERAPEUTICS INC(ARQT)1,366,6241,355,892-10,73239,68731,94511.42%-7,742
ZENAS BIOPHARMA INC(ZBIO)591,991591,991021,49511,5734.14%-9,922
Page 1 of 1